Gateway 2012: AdvantaPure - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: AdvantaPure


AdvantaPure®
145 James Way, Southampton, PA 18966
Phone 888-599-6099 or 215-526-2151
Fax 888-258-4293 or 215-526-2167
pt@advantapure.com
www.advantapure.com

Company Description:

AdvantaPure®, the high purity products division of NewAge® Industries, is designed to anticipate and meet the evolving needs of the pharmaceutical manufacturing industry. AdvantaPure is ISO 9001:2008 certified, and many of its products meet USP Class VI, FDA, ISO, and European Pharmacopoeia standards.

AdvantaPure’s tubing and hose includes AdvantaFlex® biopharmaceutical grade pump tubing, platinum cured silicone tubing and reinforced hose, and reinforced PTFE, FEP, and EPDM hose. The company focuses on single use manifold assemblies and manufactures both molded manifolds and assembled tubing sets. A variety of attachments allow for complete, ready-to-use systems. Gamma irradiation services are available.

Molded manifold connections eliminate many barbed fitting connections and their leak potentials.

Silicone, fluoropolymer and TPE tubing.

Booth Invitation:

Discover AdvantaPure’s tubing and hose products at Interphex booth 3055. Standards like silicone, TPE, and fluoropolymer tubing will be on hand as well as other products in development. Compare the advantages of single use molded manifold connections vs. barbed fittings and cable ties, plus see the new AdvantaTube Sealer and AdvantaTube Sterile Welder for TPE tubing in action.

Additional Information:
AdvantaFlex® TPE Now Available as Molded Components
The New AdvantaTube Sealer & Sterile Welder Available Now
Comparative Advantages of Molded Manifolds

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here